Antimicrobial and resource utilization with T2 magnetic resonance for rapid diagnosis of bloodstream infections: systematic review with meta-analysis of controlled studies

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.
   PubMed Web of Science ®Google Scholar
• Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200–211.
   PubMed Web of Science ®Google Scholar
• Paoli CJ, Reynolds MA, Sinha M, et al. Epidemiology and costs of sepsis in the United States-An analysis based on timing of diagnosis and severity level. Crit Care Med. 2018;46(12):1889–1897.
   PubMed Web of Science ®Google Scholar
• She RC, Alrabaa S, Lee SH, et al. Survey of physicians’ perspectives and knowledge about diagnostic tests for bloodstream infections. PLoS One. 2015;10(3):e0121493.
   PubMed Web of Science ®Google Scholar
• Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(4):881–891.
   PubMed Web of Science ®Google Scholar
• Bell BG, Schellevis F, Stobberingh E, et al. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14(1):13.
   PubMed Web of Science ®Google Scholar
• Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596.
   PubMed Web of Science ®Google Scholar
• Marquet K, Liesenborgs A, Bergs J, et al. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care. 2015;19(1):63.
   PubMedGoogle Scholar
• Harbarth S, Garbino J, Pugin J, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115(7):529–535.
   PubMed Web of Science ®Google Scholar
• Lueangarun S, Leelarasamee A. Impact of inappropriate empiric antimicrobial therapy on mortality of septic patients with bacteremia: a retrospective study. Interdiscip Perspect Infect Dis. 2012;2012:765205.
   PubMedGoogle Scholar
• Kumar A, Haery C, Paladugu B, et al. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. J Infect Dis. 2006;193(2):251–258.
   PubMed Web of Science ®Google Scholar
• Cendejas-Bueno E, Romero-Gomez MP, Mingorance J. The challenge of molecular diagnosis of bloodstream infections. World J Microbiol Biotechnol. 2019;35(4):65.
   PubMed Web of Science ®Google Scholar
• Zacharioudakis IM, Zervou FN, Mylonakis E. T2 magnetic resonance assay: overview of available data and clinical implications. J Fungi (Basel). 2018;4(2):45.
   PubMedGoogle Scholar
• Pfaller MA, Wolk DM, Lowery TJ. T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis. Future Microbiol. 2016;11(1):103–117.
   PubMed Web of Science ®Google Scholar
• Tang DL, Chen X, Zhu CG, et al. Pooled analysis of T2 Candida for rapid diagnosis of candidiasis. BMC Infect Dis. 2019;19(1):798.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Clancy CJ, Pasculle AW, et al. Performance of the T2Bacteria panel for diagnosing bloodstream infections: a diagnostic accuracy study. Ann Intern Med. 2019;170(12):845–852.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65–94.
   PubMed Web of Science ®Google Scholar
• T2 Biosystems. Publications and Presentations. 2021; Accessed 2021 Jan 2. Available from: https://www.t2biosystems.com/news-resources/publications/
   Google Scholar
• Paez A. Gray literature: an important resource in systematic reviews. J Evid Based Med. 2017;10(3):233–240.
   PubMedGoogle Scholar
• De Angelis G, Posteraro B, De Carolis E, et al. T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood. J Antimicrob Chemother. 2018;73:iv20–iv26.
   PubMed Web of Science ®Google Scholar
• Douka E, Papachatzakis I, Vrettou C, et al. Evaluation of T2MR in a Greek university intensive care unit. Paper presented at: 30th ECCMID 2020; 2020. Paris, France.
   Google Scholar
• Giannella M, Paolucci M, Roncarati G, et al. Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study. J Antimicrob Chemother. 2018;73(10):2856–2859.
   PubMed Web of Science ®Google Scholar
• Hayes JF, Turner OD, McCarty TP, et al. Influence of T2 Candida testing for rapid diagnosis of Candida infections on antifungal stewardship efforts at a large academic medical center: a retrospective single-center study. Paper presented at: IDWeek 2017; 2017. San Diego, CA.
   Google Scholar
• Turner OD, Hayes JF, McCarty TP, et al. Relationship of T2 Candida panel to disease severity, mortality and time to therapy in patients with candidemia. Paper presented at: IDWeek 2017; 2017. San Diego, CA.
   Google Scholar
• Marekovic I, Bosnjak Z, Plesko S, et al. T2Bacteria panel in diagnostics of sepsis: the first experience at the University Hospital Centre Zagreb. Paper presented at: 30th ECCMID 2020; 2020. Paris, France.
   Google Scholar
• Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60(6):892–899.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Pasculle W, Pappas PG, et al. Clinical performance of T2Bacteria among patients with bloodstream infections due to five common bacterial species. Paper presented at: ASM Microbe 2018; 2018. San Diego, CA.
   Google Scholar
• Paggi R, De Socio G, Belati A, et al. T2 magnetic resonance technology in the diagnosis of sepsis and clinical impact in patient management. Paper presented at: 30th ECCMID 2020; Paris, France.
   Google Scholar
• Patch ME, Weisz E, Cubillos A, et al. Impact of rapid, culture-independent diagnosis of candidaemia and invasive candidiasis in a community health system. J Antimicrob Chemother. 2018;73(suppl_4):iv27–iv30.
   PubMedGoogle Scholar
• Pouly O, Rouze A, Voisin B, et al. Accuracy of T2MR in diagnosing candidemia in critically ill patients: a prospective observational study. Intensive Care Med Exp. 2018;6(Suppl 2):40.
   Google Scholar
• Voigt C, Silbert S, Widen RH, et al. The T2Bacteria assay is a sensitive and rapid detector of bacteremia that can be initiated in the emergency department and has potential to favorably influence subsequent therapy. J Emerg Med. 2020;58(5):785–796.
   PubMed Web of Science ®Google Scholar
• Guzman O, Estrada S, Clark J, et al. Blood culture-independent rapid diagnostic technology for improvement of time to bacterial species ID and earlier targeted antibiotic therapy. Paper presented at: MAD-ID 2019; 2019. Orlando, FL.
   Google Scholar
• Walsh TJ, Helfgott D, Van Besien K, et al. The T2Bacteria panel is a rapid detector of bacteremia and has potential to guide therapy in patients with hematological malignancies and hematopoietic stem cell transplantation (HSCT): a pilot study of non-culture molecular diagnostics. Paper presented at: 30th ECCMID 2019; 2019.
   Google Scholar
• Wilson NM, Alangaden G, Tibbetts RJ, et al. T2 Magnetic Resonance assay improves timely management of candidemia. Journal of Antimicrobial Stewardship. 2017;1:12–18.
   Google Scholar
• Chaudhry Z, Vahia A, Askar S, et al. Impact of T2 Candida panel on species specific anti-fungal de-escalation. Paper presented at: IDWeek 2018; 2018. San Francisco, CA.
   Google Scholar
• Chaudhry Z, Vahia A, Kathuria P, et al. Evaluation of the T2Candida panel as an antifungal stewardship tool in transplant and non-transplant patients at a tertiary care center. Paper presented at: IDWeek 2019; 2019. Washington, D.C.
   Google Scholar
• Dwivedi S, Ordaya E, Kezlarian B, et al. Novel T2 magnetic resonance assay compared to standard blood cultures for detection of candidemia. Paper presented at: IDWeek 2016; 2016. New Orleans, LA.
   Google Scholar
• Hussain N, Vahia A, Chaudhry Z, et al. Novel T2 Candida assay compared to blood cultures for detection of candidemia in transplant and non-transplant patients. Paper presented at: IDWeek 2018; 2018. San Francisco, CA.
   Google Scholar
• Kenney R, Dwivedi S, Kendall R, et al. Implementation of T2 magnetic resonance into the antimicrobial stewardship program improves management of candidemia at HFHS. Paper presented at: IDWeek 2016; 2016. New Orleans, LA.
   Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127(9):820–826.
   PubMed Web of Science ®Google Scholar
• Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443–3457.
   PubMed Web of Science ®Google Scholar
• National Library of Medicine. NIH data sharing policies. 2020; https://www.nlm.nih.gov/NIHbmic/nih_data_sharing_policies.html. Accessed 2020 Dec 19.
   Google Scholar
• Seitz T, Baumgartner S, Wenisch C, et al. Evaluation of the clinical impact of the T2MR for the diagnosis of bloodstream infections. Open Forum Infect Dis. 2019;6:S89.
   Google Scholar
• Bilir SP, Ferrufino CP, Pfaller MA, et al. The economic impact of rapid Candida species identification by T2Candida among high-risk patients. Future Microbiol. 2015;10(7):1133–1144.
   PubMed Web of Science ®Google Scholar
• Shehadeh F, Zacharioudakis IM, Zervou FN, et al. Cost-effectiveness of rapid diagnostic assays that perform directly on blood samples for the diagnosis of septic shock. Diagn Microbiol Infect Dis. 2019;94(4):378–384.
   PubMed Web of Science ®Google Scholar
• Zacharioudakis IM, Zervou FN, Shehadeh F, et al. Cost-effectiveness of molecular diagnostic assays for the therapy of severe sepsis and septic shock in the emergency department. PLoS One. 2019;14(5):e0217508.
   PubMed Web of Science ®Google Scholar
• Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51–77.
   PubMed Web of Science ®Google Scholar
• Timbrook TT, Morton JB, McConeghy KW, et al. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and Meta-analysis. Clin Infect Dis. 2017;64(1):15–23.
   PubMed Web of Science ®Google Scholar
• D’Onofrio V, Salimans L, Bedenic B, et al. The clinical impact of rapid molecular microbiological diagnostics for pathogen and resistance gene identification in patients with sepsis: a systematic review. Open Forum Infect Dis. 2020;7(10):ofaa352.
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Zacharioudakis IM, Clancy CJ, et al. Efficacy of T2 magnetic resonance assay in monitoring candidemia after initiation of antifungal therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial. J Clin Microbiol. 2018;56(4):56.
   Web of Science ®Google Scholar
• Roberts KM, Lapp HS, Barringer GE, et al. T2Bacteria panel: a rapid, culture-independent assay for identification of sepsis causative agents. Paper presented at: ASM Microbe 2018; 2018. Atlanta, GA.
   Google Scholar
• Diallo K, Thilly N, Luc A, et al. Management of bloodstream infections by infection specialists: an international ESCMID cross-sectional survey. Int J Antimicrob Agents. 2018;51(5):794–798.
   PubMed Web of Science ®Google Scholar